Top Markets
#1 DogBull DogBull +108.33%
#2 ADO Protocol ADO Protocol +52.43%
#3 MarsCoin MarsCoin +49.06%
#4 Siacoin Siacoin +44.45%
#5 Nockchain Nockchain +22.09%
#6 Ontology Gas Ontology Gas +20.89%
#7 Apertum Apertum +19.60%
#8 Useless Coin Useless Coin +18.44%
#9 Falcon Finance Falcon Finance +17.38%
#10 UnifAI Network UnifAI Network +16.23%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Rank in Stocks #15297
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Share Price
$6.57
Market Cap
$357.27M
Change (1 day)
-0.83%
Change (1 year)
-61.68%
Country
US
Trade Upstream Bio, Inc. (UPB)

Category

Healthcare
Stock price history for Upstream Bio, Inc. (UPB)
Highest end of day price: $6.61 on 2026-09-01

Lowest end of day price: $24.44 on 2024-10-01
Stock price history of Upstream Bio, Inc. from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -45.19%
2025 43.52%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.99 40.91%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 45.51%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.15 502.53%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $747.56 4.77%
CH